Human Performance Lab

Ludger blood spot

The Human Performance Lab (HPL) is the latest addition to Ludger's Precision Medicine portfolio.

HPL is a research and development facility, which builds on Ludger's existing research programmes investigating the relationship between the structure and function of protein glycosylation and precision medicine for chronic or inflammatory diseases.

In particular, the focus of HPL research activities will be on better understanding the effects of lifestyle factors on health and inflammatory biomarkers, such as glycosylation, in the body - and how these change over time.

A primary objective is the development of explanatory models of aetiology to better understand and predict changes in levels of inflammation in the body.

For more information, visit

Current Activities

Longitudinal Case Study

This project seeks to better understand the relationship between glycan markers of systemic inflammation in the body and key lifestyle factors, such as nutrition, exercise and sleep.

Lifestyle Intervention Study

In collaboration with Wellfinity, Ludger will be investigating the effect of a 10-week exercise (boxing) intervention on levels of inflammation in the body in a sample of 20 healthy volunteers.

Workshop Series (2019)

More details coming soon


Dr. Christel Gudberg

Dr. Christel Gudberg
Lead, Ludger Human Performance Lab

Dr. Daryl Fernandes

Dr. Daryl Fernandes
Chief Executive